Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2004.041277v1, 2005; 10.1373/clinchem.2004.041277
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.041277v1
51/3/516    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rittersma, S. Z.H.
Right arrow Articles by de Winter, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rittersma, S. Z.H.
Right arrow Articles by de Winter, R. J.

Received on August 6, 2004
Accepted on December 29, 2004

Molecular Diagnostics and Genetics

Relationship between In Vitro Lipopolysaccharide-Induced Cytokine Response in Whole Blood, Angiographic In-Stent Restenosis, and Toll-Like Receptor 4 Gene Polymorphisms

Saskia Z.H. Rittersma 1*, Johanna A. Kremer Hovinga 2, Karel T. Koch 1, S. Matthijs Boekholdt 1, Benien E. van Aken 2, Arko Scheepmaker 1, Matthijs Bax 1, Carl E. Schotborgh 1, Jan J. Piek 1, Jan G.P. Tijssen 1, Pieter H. Reitsma 2, Robbert J. de Winter 1

1 Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
2 Department of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

* To whom correspondence should be addressed. E-mail: z.h.rittersma{at}amc.uva.nl.

Background: In coronary in-stent restenosis (ISR), a substantial contribution of inflammation is assumed. We evaluated the association between polymorphisms in the Toll-like receptor 4 (TLR4) gene and cytokine response after lipopolysaccharide (LPS) challenge and the development of ISR.

Methods: Patients were included after successful elective stent placement in a native coronary artery and were scheduled for follow-up angiography after 6 months. Quantitative coronary analysis was performed off-line. Patient whole blood was challenged with LPS for 24 h. Baseline and stimulated concentrations of interleukin (IL)-1{beta}, IL-6, tumor necrosis factor-{alpha}, and IL-10 were assessed by ELISA. Two cosegregating single-nucleotide polymorphisms in the TLR4 gene (Asp299Gly and Thr399Ile) were analyzed by allele-specific PCR amplification of genomic DNA.

Results: A total of 236 consecutive patients were included, and 40 (17%) developed ISR. Median baseline and stimulated cytokine concentrations did not differ between patients with and without ISR. In multivariate analysis, male sex, unstable angina, hypertension, and chronic total occlusion were predictors of ISR. TLR4 genotypes were not associated with baseline or stimulated cytokine concentrations or with angiographic variables at follow-up.

Conclusions: In vitro cytokine response to LPS challenge is not increased in patients with ISR. Functionality of the TLR4 Asp299Gly polymorphism could not be demonstrated in this setting, and this polymorphism was not associated with angiographic outcome, calling into question its role in the progression of neointimal tissue growth.




The following articles in journals at HighWire Press have cited this article:


Home page
Innate ImmunityHome page
C. Hermann
Review: Variability of host pathogen interaction
Innate Immunity, August 1, 2007; 13(4): 199 - 218.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Association for Clinical Chemistry.